UBS Group
ONCR

UBS Group’s Oncorus, Inc. ONCR Stock Holding History

UBS Group’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,650
Closed -$5.04K – 10241
2023
Q1 		$5.04K Buy
+14,650
New +$5.47K ﹤0.01% 8092
2022
Q4 		– Sell
-3,604
Closed -$3K – 11481
2022
Q3 		$3K Sell
3,604
-4,412
-55% -$5.66K ﹤0.01% 9649
2022
Q2 		$10K Buy
+8,016
New +$10.9K ﹤0.01% 8063
2022
Q1 		– Sell
-3,142
Closed -$17K – 11263
2021
Q4 		$17K Buy
+3,142
New +$24.3K ﹤0.01% 8107
2021
Q3 		– Sell
-60,940
Closed -$841K – 10375
2021
Q2 		$841K Buy
60,940
+58,431
+2,329% +$902K ﹤0.01% 4326
2021
Q1 		$35K Sell
2,509
-4,712
-65% -$97.6K ﹤0.01% 6887
2020
Q4 		$233K Buy
+7,221
New +$167K ﹤0.01% 5150

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return